Content about Peptides

August 30, 2012
FDA approves Linzess for chronic constipation, irritable bowel syndrome

The Food and Drug Administration has approved a new drug for treating bowel diseases made by Ironwood Pharmaceuticals, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating bowel diseases made by Ironwood Pharmaceuticals, the agency said Thursday.

February 21, 2012
Jarrow Formulas product featured on 'The Dr. Oz Show'

The syndicated health program "The Dr. Oz Show" last week featured Jarrow Formulas' Carnosine supplement, Jarrow announced.

LOS ANGELES — The syndicated health program "The Dr. Oz Show" last week featured Jarrow Formulas' Carnosine supplement, Jarrow announced.

August 26, 2011
FDA approves Shire autoimmune disorder drug

The Food and Drug Administration has approved a drug made by Shire for a rare autoimmune condition, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Shire for a rare autoimmune condition, the agency said.

The FDA announced the approval of Firazyr (icatibant) for acute attacks of hereditary angioedema in patients ages 18 years and older. HAE, which affects fewer than 30,000 people in the United States, results from improper function of C1 inhibitor, a protein that regulates how certain immune system and blood clotting pathways function.

February 28, 2011
Once again, Shire seeks FDA approval for Firazyr

British drug maker Shire again is trying to win approval for a hereditary angioedema drug that the Food and Drug Administration had previously declined to approve.

DUBLIN — British drug maker Shire again is trying to win approval for a hereditary angioedema drug that the Food and Drug Administration had previously declined to approve.

Shire said Monday that it had submitted a response to the "not approvable letter" the FDA sent to German subsidiary Jerini AG in April 2008 for the drug Firazyr (icatibant).